Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.24(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2550
+0.0017(+0.13%)
Bitcoin GBP
50,886.80
-225.86(-0.44%)

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.2420

-0.0219

(-8.30%)

At close: 04:00PM EDT

0.2404

-0.00

(-0.66%)

After hours:

05:04PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	1.47M
Enterprise value	-6.90M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.20
Price/book (mrq)	0.11
Enterprise value/revenue	-1.26
Enterprise value/EBITDA	1.08

Trading information

Stock price history

Beta (5Y monthly)	0.48
52-week change ³	-78.18%
S&P500 52-week change ³	22.38%
52-week high ³	2.0800
52-week low ³	0.2280
50-day moving average ³	0.3416
200-day moving average ³	0.5361

Share statistics

Avg vol (3-month) ³	405.82k
Avg vol (10-day) ³	643.5k
Shares outstanding ⁵	6.06M
Implied shares outstanding ⁶	6.06M
Float ⁸	4.84M
% held by insiders ¹	1.36%
% held by institutions ¹	13.29%
Shares short (15 Apr 2024) ⁴	114.49k
Short ratio (15 Apr 2024) ⁴	0.24
Short % of float (15 Apr 2024) ⁴	1.89%
Short % of shares outstanding (15 Apr 2024) ⁴	1.89%
Shares short (prior month 15 Mar 2024) ⁴	56.97k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	06 Jul 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:25
Last split date ³	07 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-115.75%
Operating margin (ttm)	-137.47%

Management effectiveness

Return on assets (ttm)	-27.17%
Return on equity (ttm)	-46.86%

Income statement

Revenue (ttm)	5.49M
Revenue per share (ttm)	1.22
Quarterly revenue growth (yoy)	164.00%
Gross profit (ttm)	N/A
EBITDA	-6.78M
Net income avi to common (ttm)	-6.35M
Diluted EPS (ttm)	-0.4200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	9.58M
Total cash per share (mrq)	1.58
Total debt (mrq)	1.17M
Total debt/equity (mrq)	9.14%
Current ratio (mrq)	7.03
Book value per share (mrq)	2.25

Cash flow statement

Operating cash flow (ttm)	-6.34M
Levered free cash flow (ttm)	-4.19M